Canadian pharmacy and therapeutics news: recalls, shortages, guideline updates and developments in practice.
Two Canadian vaccine authorizations open new options for adults 50 and older, but approval is distinct from seasonal supply and public funding.
Nov 8, 2026 · 3 min read Read briefing
Health Canada has expanded risankizumab’s Canadian indication to children aged 6 to under 18 with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. The approval changes the product label; coverage decisions remain separate.
Oct 23, 2026 · 3 min read Read briefing
Health Canada has approved EPKINLY (epcoritamab) with lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma, based on Phase 3 trial results showing a 79% reduction in the risk of disease progression or death versus the standard regimen alone.
Sep 24, 2026 · 3 min read Read briefing
Sandoz has become the third company with Health Canada approval to sell generic semaglutide, but the product has no launch date -- and arrives while both existing generics, from Dr. Reddy's and Apotex, are in officially declared shortages.
Sep 22, 2026 · 3 min read Read briefing
Health Canada has authorized an Omicron XFG-adapted Pfizer-BioNTech COVID-19 vaccine for people 6 months and older, and pharmacies should plan to transition ordering and counselling to the updated formulation.
Sep 19, 2026 · 3 min read Read briefing